U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT07491016) titled 'Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis' on March 18.
Brief Summary: The aim of this study is to observe the clinical efficacy and safety of telitacicept combined with baricitinib in the treatment of D2TRA patients
Study Start Date: March 01
Study Type: OBSERVATIONAL
Condition:
Telitacicept
Treatment Compliance
Rheumatoid Arthritis
Recruitment Status: RECRUITING
Sponsor: Zhejiang Provincial People's Hospital
Information provided by (Responsible Party): Zhenhua Ying, Zhejiang Provincial People's Hospital
Published by HT Digital Content Services with permission from He...